Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

VIB and Johnson & Johnson set up a new Fund to identify projects with potential for commercialization

24.10.2006
VIB, the Flanders Interuniversity Institute for Biotechnology, Johnson & Johnson's Corporate Office of Science and Technology (COSAT) and Johnson & Johnson Pharmaceutical Research and Development (J&J PRD) have established a first Proof-of-Concept Fund at the value of 500 000 EUR.

The primary goal of the Fund is to foster VIB proof-of-concept research (technologies, molecular mechanisms of disease ...). The Fund focuses on collaborations between different VIB departments and has to validate frontline inventions in life sciences research at VIB.

Proof-of-Concept Fund

The further purpose of this program is to identify research with potential for commercialization. Projects should be at a developmental stage at which carefully designed studies are likely to provide proof of concept. This project is unique in Europe, it is the first time that such a fund has been supported by COSAT and J&J PRD at a European University or Academic Institution. The aim of this fund, is to sow the seeds of (a) larger collaboration(s) with J&J and to stimulate interactions between researchers of J&J PRD and COSAT on the one hand and VIB on the other hand. The Fund is really meant to form the first building blocks of a bridge between two major players (one in the industrial and one in the academic world) in biotechnology and pharmaceutical sciences in Flanders, Belgium.

... more about:
»COSAT »Collaboration »J&J »Johnson »PRD

The winning projects

The projects are pre-screened by a VIB committee and the final selection will be done by COSAT and J&J PRD team. 4 Projects will be selected on the basis of several criteria (most important criteria are: scientific relevance of research topic, excellence of the proposed research, commercial potential and added value of interdepartmental collaboration).

Each winning project receives 125 000 EUR, which is sufficient to pay one post doctoral researcher and his bench fee for one year. In this manner one hopes to sow the seeds for larger collaborations between VIB and J&J.

Kick-Off Meeting

On Monday, October 23, 2006 (3-7 pm) the 4 winning teams as well as relevant persons of J&J PRD, COSAT and VIB will kick-off the fund with presentations of the winning projects for all interested VIB researchers.

Sooike Stoops | alfa
Further information:
http://www.vib.be

Further reports about: COSAT Collaboration J&J Johnson PRD

More articles from Life Sciences:

nachricht Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland

nachricht Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>